Vertex Pharmaceuticals
VRTX
#149
Rank
C$197.82 B
Marketcap
C$780.98
Share price
3.60%
Change (1 day)
34.27%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): C$7.02 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$12.58 Billion. In 2025 the company made an earning of C$6.73 Billion, an increase over its 2024 earnings that were of C$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$7.02 B4.38%
2025 C$6.73 B1627.59%
2024 C$0.38 B-93.69%
2023 C$6.17 B3.19%
2022 C$5.98 B53.56%
2021 C$3.89 B-12.06%
2020 C$4.43 B118.45%
2019 C$2.02 B120.64%
2018 C$0.91 B1473.64%
2017 C$58.43 M197.6%
2016 C$19.63 M-102.97%
2015 -C$0.67 Billion-28.46%
2014 -C$0.93 Billion-51.5%
2013 -C$1.91 Billion-30584.68%
2012 C$6.25 M-95.47%
2011 C$0.13 B
2009 -C$0.83 Billion
2007 -C$0.58 Billion83.1%
2006 -C$0.32 Billion59.02%
2005 -C$0.2 Billion3.28%
2004 -C$0.2 Billion-38.16%
2003 -C$0.31 Billion
2000 -C$53.11 Million-20.38%
1999 -C$66.7 Million31.62%
1998 -C$50.68 Million91.05%
1997 -C$26.53 Million-36.24%
1996 -C$41.6 Million12.45%
1995 -C$37 Million27.4%
1994 -C$29.04 Million-1833.33%
1993 C$1.67 M-112.12%
1992 -C$13.83 Million175%
1991 -C$5.03 Million-12.2%
1990 -C$5.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.58 B 419.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$12.14 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.73 Billion-138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.73 B 52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.62 B 136.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$70.1 Million-101.00%๐Ÿ‡บ๐Ÿ‡ธ USA